- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Steven R. Feldman on Managing Psoriasis in Patients With Metabolic Syndrome
Steven R. Feldman, MD, PhD, professor of dermatology, Wake Forest School of Medicine, discusses the challenges clinicians face when managing psoriasis in patients who also have metabolic syndrome.
Steven R. Feldman, MD, PhD, professor of dermatology, Wake Forest School of Medicine, discusses the challenges clinicians face when managing psoriasis in patients who also have metabolic syndrome.
Transcript
What are some of the challenges clinicians face when managing psoriasis in patients who also have metabolic syndrome?
Psoriasis is challenging whether you have metabolic syndrome or not. There’s the challenge of making the right diagnosis. That’s not hard; we recognize psoriasis when we see it. Prescribing the right therapy can be difficult. There are so many variations of psoriasis, so many different treatments available—creams, ultraviolet light treatments, a variety of oral and injectable medicines. We have to choose from among those.
When you have a patient who has metabolic syndrome, it complicates the decisions, perhaps, a little bit, or if not complicate it, at least leads you in certain pathways as to what to use. For example, metabolic syndrome may be associated with central obesity. Those patients may have a fatty liver, and therefore, you may want to steer away from a drug like methotrexate and move towards an injectable medicine.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
